BullishMEDIUM severityEarnings1h ago

GE HealthCare Technologies Non-GAAP EPS of $1.34 beats by $0.14, revenue of $5.51B beats by $160M, raises FY guidance

GE HealthCare Technologies Non-GAAP EPS of $1.34 beats by $0.14, revenue of $5.51B beats by $160M, raises FY guidance — $GEHC one-month chart
$GEHC daily closes over the past month · Wook of Wall Street artwork from market data
WOOKAI ASSISTANTREADY
WOOK AIASK ANYTHING · NEVER ADVISES

Meet Wook AI, your friendly assistant. Ask how something works, about any company, fund or coin, or have it do the math — live figures come from this site’s own lookups, and you’ll see which ones it used.

Wook analysis

What it means

Key points
  • What to watch: GE HealthCare Technologies Inc. (GEHC) raised guidance toward $1.34 — the useful detail is whether demand drove it or a one-time item did.
  • How the stock is trading: $GEHC +6.44% in the latest session.
  • Timing: It came out pre-market, so the next session was the first that could react.
Amount$1.34
Amount$0.14
Amount$5.51 billion
Amount$160 million

Where the stock stands

$GEHC last traded at $75.69, +6.44% on the session. That puts it 16% shy of its 52-week high of $89.77 and 29% clear of its low of $58.75 — around the middle of the range. Over the year it has ranged 53% from low to high: a wide band, so a several-percent week is just a week. These are latest-session quotes, not live prices — the live tape is on the $GEHC page.

How much coverage it is getting

In the last 30 days Wook has filed 2 stories about $GEHC — 1 of them this week. At its 30-day pace you would expect less than one a week, so this week is running well ahead of normal; the press has found a reason to keep writing. Across those stories 1 read bullish, 1 neutral and 0 bearish. This one reads bullish, so it sits in step with most of the run. This is the only one from Seeking Alpha; the rest came from other outlets. 12 related stories from the same name or desk are listed beside this one.

The bigger picture

With earnings, the number matters less than the number versus expectations — and guidance often matters more than both. A beat paired with a soft outlook can still get a cold reception. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.

Coming up

$GEHC earnings today. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the hard numbers get the last word soon.

What to watch next

For the receipts, the $GEHC page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. And Wook AI, up top, will happily do the math — how far $GEHC sits from its high, or how this week's coverage stacks up.

How this analysis was made

Seeking Alpha published it, and Wook filed it under Earnings. It reads bullish at medium severity because of “beat” in the wording, with nothing on the bearish side to offset it. It was matched to $GEHC. It carried $1.34, $0.14, $5.51 billion and $160 million, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.

The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.

Discussion

No one has weighed in yet. Start the discussion on this story.

What happened after this published

Seeking Alpha published this on October 28, 2026. $GEHC has moved +2.23% ($74.04 to $75.69). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.

Headline and link are attributed to Seeking Alpha. Wook of Wall Street is an independent research tool and is not affiliated with Seeking Alpha. Nothing here is financial advice or a recommendation — research and educational content only.